Nombre del producto:3-(3-methylcyclobutyl)-3H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridine

IUPAC Name:3-(3-methylcyclobutyl)-3H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridine

CAS:1858938-08-5
Fórmula molecular:C10H16N4
Pureza:95%+
Número de catálogo:CM408261
Peso molecular:192.27

Unidad de embalaje Stock disponible Precio($) Cantidad
CM408261-100mg 4-5 Weeks ŹIJŗ
CM408261-250mg 5-6 Weeks ǪǪůů
CM408261-500mg 5-6 Weeks ǪŹŗȃ
CM408261-1g 6-7 Weeks ľƿůƥ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1858938-08-5
Fórmula molecular:C10H16N4
Punto de fusión:-
Código de sonrisas:CC1CC(C1)N1N=NC2=C1CNCC2
Densidad:
Número de catálogo:CM408261
Peso molecular:192.27
Punto de ebullición:
Nº Mdl:
Almacenamiento:

Category Infos

Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.